MPI Research Presents in Sweden and the Netherlands

//MPI Research Presents in Sweden and the Netherlands

MPI Research Presents in Sweden and the Netherlands

MPI Research will be sharing our scientific highlights at two upcoming European meetings, both being held June 17-20, 2012.

Ali S. Faqi, PhD, DVM, DABT, Senior Director of Developmental and Reproductive Toxicology (DART) and Senior Principal Study Director at MPI Research, will present “Developmental Toxicity Study of Propofol Injectable Emulsion in Rats” at the 48th Annual European Societies of Toxicology Meeting (Eurotox) in Stockholm, Sweden.

Jim Vrbanac, PhD, Director of Absorption, Distribution, Metabolism, and Excretion (ADME) and Senior Study Director at MPI Research, will present “Rapid Quantitative Method Development for Drug Metabolites (DMs) in Human Plasma Using Isotope Dilution” at the 12th European International Society for the Study of Xenobiotics (ISSX) meeting, in the Netherlands.

On behalf of the entire team at MPI Research, proudly serving pharmaceutical and biotechnology companies worldwide, we look forward to greeting you at booth #5 at Eurotox and booth #36 at ISSX!

By | 2017-07-04T10:29:11+00:00 June 20th, 2012|News|Comments Off on MPI Research Presents in Sweden and the Netherlands

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.